Margarida Maia is a science writer for Alzheimer's News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
Experimental blarcamesine (Anavex 2-73) was able to slow cognitive and functional decline in early Alzheimer’s patients over a year, data show.| Alzheimer's News Today
Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface of immune T-cells.| Alzheimer's News Today
Category archive page for News.| Alzheimer's News Today
Buntanetap, a small molecule from Annovis Bio, improved cognitive function in people with mild Alzheimer’s with certain biomarkers.| Alzheimer's News Today
